 Orgenesis NASDAQ:ORGS Inc said it has entered into a definitive securities purchase agreement with certain investors for a private placement for which it expects to receive gross proceeds of approximately 14.8 million before deducting related offering expenses. The company said the placement will see the sale of 4,933,333 shares of the companys common stock at a purchase price of 3.00 per share and warrants to purchase up to 1,000,000 shares of common stock at an exercise price of 4.50 per share. 